₹294.33
Above FV▼ -29.9% against the close used
Model range ₹166.73 – ₹601.38
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹166.73Fair value₹294.33Bull₹601.38
FairClose
52-week traded range
52W low ₹319.6552W high ₹531.95
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Trualt Bioenergy Limited closed at ₹419.65, 42.6% above the consensus fair value of ₹294.33 drawn from 9 valuation models.
Financial DNA score 44/100 — Average. P/E of 22.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹222.11
-47.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹270.87
-35.5%
√(22.5 × EPS × BVPS)
EPS=11.19, BVPS=291.42 · outside Graham range (P/E 22.8, P/B 1.4) — asset-light, treat as a rough floor
Graham Formula
₹503.95
+20.1%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹166.73
-60.3%
EPS × 14.9x (sector P/E)
EPS=11.19, Sector P/E=14.9x
Peter Lynch (PEG)
₹273.04
-34.9%
EPS × Growth% (PEG = 1 is fair)
EPS=11.19, g=24.4%
EV/EBITDA
₹601.38
+43.3%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=3.76B
Book Value (P/B)
₹173.40
-58.7%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=291.42, ROE=8.4%, g=6%, r=10%
Reverse DCF
₹419.65
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 15.6% | Historical: 24.4%
Margin of Safety
₹218.19
-48.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=290.92, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.